Oct4 pseudogenes are transcribed in cancers

被引:165
作者
Suo, GL
Han, J
Wang, X
Zhang, JY
Zhao, YN
Zhao, YH
Dai, JW [1 ]
机构
[1] Chinese Acad Sci, Ctr Mol Dev Biol, Inst Genet & Dev Biol, Beijing 100080, Peoples R China
[2] Chinese Acad Sci, Grad Sch, Beijing 100080, Peoples R China
基金
中国国家自然科学基金;
关键词
Oct4; pseudogene; transcription; cancer cell line; cancer tissue;
D O I
10.1016/j.bbrc.2005.09.157
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Octamer-binding transcription factor 4 (Oct4) plays a critical role for maintaining pluripotent and the self-renewing state of stem cells. Recent studies demonstrated that Oct4 gene was expressed in human cancers. Six pseudogenes of Oct4 have been proposed by using bioinformatics approach to analyze the genomic nucleotide sequences. Here, we reported that an Oct4 pseudogene localized in human chromosome 10 (Oct4-pg5) and a pseudogene in chromosome 8 (Oct4-pg1)were transcribed in cancer cell lines as well as cancer tissues tested, and the), were not found transcribed in embryonic carcinoma cells, human fibroblasts, and normal tissues tested. Our results suggest that pseudogenes Oct4-pg5 and Oct4-pg1 may be involved in the regulation of Oct4 gene activity thus Might be pertinent to carcinogenesis. Transcription of these Oct4 pseudogenes may have contributed artifacts to the current knowledge of Oct4 gene expression and function in cancers. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1047 / 1051
页数:5
相关论文
共 17 条
  • [1] Oct-3/4 is a dose-dependent oncogenic fate determinant
    Gidekel, S
    Pizov, G
    Bergman, Y
    Pikarsky, E
    [J]. CANCER CELL, 2003, 4 (05) : 361 - 370
  • [2] Transcribed processed pseudogenes in the human genome: an intermediate form of expressed retrosequence lacking protein-coding ability
    Harrison, PM
    Zheng, DY
    Zhang, ZL
    Carriero, N
    Gerstein, M
    [J]. NUCLEIC ACIDS RESEARCH, 2005, 33 (08) : 2374 - 2383
  • [3] An expressed pseudogene regulates the messenger-RNA stability of its homologous coding gene
    Hirotsune, S
    Yoshida, N
    Chen, A
    Garrett, L
    Sugiyama, F
    Takahashi, S
    Yagami, K
    Wynshaw-Boris, A
    Yoshiki, A
    [J]. NATURE, 2003, 423 (6935) : 91 - 96
  • [4] Korneev SA, 1999, J NEUROSCI, V19, P7711
  • [5] Looijenga LHJ, 2003, CANCER RES, V63, P2244
  • [6] Specific knockdown of Oct4 and β2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells
    Matin, MM
    Walsh, JR
    Gokhale, PJ
    Draper, JS
    Bahrami, AR
    Morton, I
    Moore, HD
    Andrews, PW
    [J]. STEM CELLS, 2004, 22 (05) : 659 - 668
  • [7] Vertebrate pseudogenes
    Mighell, AJ
    Smith, NR
    Robinson, PA
    Markham, AF
    [J]. FEBS LETTERS, 2000, 468 (2-3) : 109 - 114
  • [8] Human embryonic genes re-expressed in cancer cells
    Monk, M
    Holding, C
    [J]. ONCOGENE, 2001, 20 (56) : 8085 - 8091
  • [9] Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4
    Nichols, J
    Zevnik, B
    Anastassiadis, K
    Niwa, H
    Klewe-Nebenius, D
    Chambers, I
    Schöler, H
    Smith, A
    [J]. CELL, 1998, 95 (03) : 379 - 391
  • [10] A NOVEL OCTAMER BINDING TRANSCRIPTION FACTOR IS DIFFERENTIALLY EXPRESSED IN MOUSE EMBRYONIC-CELLS
    OKAMOTO, K
    OKAZAWA, H
    OKUDA, A
    SAKAI, M
    MURAMATSU, M
    HAMADA, H
    [J]. CELL, 1990, 60 (03) : 461 - 472